Included under terms of UK Non-commercial Government License.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Westwood M, Ramaekers B, Lang S, et al. ImmunoCAP® ISAC and Microtest for multiplex allergen testing in people with difficult to manage allergic disease: a systematic review and cost analysis. Southampton (UK): NIHR Journals Library; 2016 Sep. (Health Technology Assessment, No. 20.67.)
ImmunoCAP® ISAC and Microtest for multiplex allergen testing in people with difficult to manage allergic disease: a systematic review and cost analysis.
Show details- Allergen
A substance that causes an allergic reaction.
- Antibody
A large Y-shaped protein, also known as an immunoglobulin, which is used by the immune system to identify pathogens.
- Cost-effectiveness analysis
An economic analysis that converts effects into health terms and describes the costs for additional health gain.
- Cross-immunoreactive
An antibody which can interact or bind with more than one antigen.
- Cross-sensitisation
The process of producing a specific IgE antibody from one of several homologous allergens.
- False negative
Incorrect negative test result – number of diseased persons with a negative test result.
- False positive
Incorrect positive test result – number of non-diseased persons with a positive test result.
- Homologous allergens
Allergen molecules with very similar molecular structures.
- Immunoglobulin E
A type of antibody that is found in mammals and which mediates allergic responses.
- Immunoreactive
Interaction between an allergen and an antibody.
- Index test
The test whose performance is being evaluated.
- Meta-analysis
Statistical techniques used to combine the results of two or more studies and obtain a combined estimate of effect.
- Opportunity costs
The cost of forgone outcomes that could have been achieved through alternative investments.
- Publication bias
Bias arising from the preferential publication of studies with statistically significant results.
- Quality-adjusted life-year
A measure of health gain, used in economic evaluations, in which survival duration is weighted or adjusted by the patient’s quality of life during the survival period.
- Quality of life
An individual’s emotional, social and physical well-being and their ability to perform the ordinary tasks of living.
- Receiver operating characteristic curve
A graph that illustrates the trade-offs between sensitivity and specificity which result from varying the diagnostic threshold.
- Reference standard
The best currently available method for diagnosing the target condition. The index test is compared against this to allow calculation of estimates of accuracy.
- Sensitisation
The process of producing a specific immunoglobulin E antibody from exposure to a specific allergen.
- Sensitivity
Proportion of people with the target disorder who have a positive test result.
- Specificity
Proportion of people without the target disorder who have a negative test result.
- True negative
Correct negative test result – number of non-diseased persons with a negative test result.
- True positive
Correct positive test result – number of diseased persons with a positive test result.
- Glossary - ImmunoCAP® ISAC and Microtest for multiplex allergen testing in peopl...Glossary - ImmunoCAP® ISAC and Microtest for multiplex allergen testing in people with difficult to manage allergic disease: a systematic review and cost analysis
- Bacillus cereus strain FSL M8-0473, whole genome shotgun sequencing projectBacillus cereus strain FSL M8-0473, whole genome shotgun sequencing projectgi|1151518747|gb|MUAP00000000.1|MUA 0000Nucleotide
- SRX12418530 (1)SRA
- Homo sapiens cyclin dependent kinase 9 (CDK9), mRNAHomo sapiens cyclin dependent kinase 9 (CDK9), mRNAgi|1653962463|ref|NM_001261.4|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...